Sort
16,300 grants matching “fatty liver disease”
Translational analysis of a novel intervention to promote healthy aging.
$616,424Ricki J Colman · University Of Wisconsin-Madison · R01 · FY2025 · AG
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases
$616,187Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases
$616,187Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Glycopathology of HCC: identification of the source cells of serum fucosylation
$615,632Anand S Mehta · Medical University Of South Carolina · U01 · FY2020 · CA
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
$615,301Todd R. Golub · Broad Institute, Inc. · R01 · FY2015 · CA
Neuroinflammation and Alzheimer's Disease Imaging Biomarkers in Midlife Obesity
$615,241Cyrus A Raji · Washington University · R01 · FY2025 · AG
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$615,034Veronica Wendy Setiawan · University Of Southern California · R01 · FY2023 · MD
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2019 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2017 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2025 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2023 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2022 · HL
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$614,842Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2025 · AA
Mechanism of ER Protein Misfolding-Induced Mitochondrial Dysfunction
$614,427Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · DK
Mechanism of ER protein misfolding-induced mitochondrial dysfunction
$614,427Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · DK
Mechanism of ER Protein Misfolding-Induced Mitochondrial Dysfunction
$614,427Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · DK
Mechanism of ER protein misfolding-induced mitochondrial dysfunction
$614,427Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK
Licensing LncRNAs in Atherosclerosis
$614,422Tamer Sallam · University Of California Los Angeles · R01 · FY2024 · HL
Mitochondrial DAMPs-driven Mechanisms of Liver Fibrosis in NASH
$614,322Yury Popov · Beth Israel Deaconess Medical Center · R01 · FY2025 · DK
Exposome and Precision Medicine in NAFLD
$614,249Matthew C Cave · University Of Louisville · R01 · FY2021 · ES
The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
$614,168Arya Mani · Yale University · R01 · FY2025 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics
$613,874Sonia Michael Najjar · Ohio University Athens · R01 · FY2019 · MD
HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression
$613,493Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2016 · DK
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
$613,426Mariana Gerschenson · University Of Hawaii At Manoa · R01 · FY2012 · AI
Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma
$613,402Yazhen Zhu · University Of California Los Angeles · R01 · FY2024 · CA